Paper18486992
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Hansson O and 8 others. Neurobiol Aging, 2010. Cited by 238 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Papers, record 18486992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18486992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Amyloid beta-Peptides | Major topic |
| Cognition Disorders | Major topic |
| Peptide Fragments | Major topic |
| Aged | |
| Aged, 80 and over | |
| Biomarkers | |
| Cohort Studies | |
| Disease Progression | |
| Eating | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Proportional Hazards Models | |
| Risk Factors | |
| Time Factors |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 18963255 | Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. | https://conductscience.org/library/papers/18963255 |
Source PubMed
Cited by136
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 238 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42723835 | Expression differences and diagnostic efficacy of core plasma biomarkers in Alzheimer's disease, cerebral small vessel disease and healthy adults. | Front Neurol | 2026 | https://conductscience.org/library/papers/42723835 | PubMed |
| 42554173 | Plasma Concentrations of Amyloid-β Peptides, BACE-1, and Tau Proteins in Alzheimer's Disease. | Turk J Pharm Sci | 2026 | https://conductscience.org/library/papers/42554173 | PubMed |
| 41883006 | Generalizability of blood-based biomarkers of Alzheimer's disease and related dementias in a multicultural cohort of older adults: The effect of adjustment for kidney function. | J Alzheimers Dis | 2026 | https://conductscience.org/library/papers/41883006 | PubMed |
| 41756762 | The 2024 NIA-AA biological definition of Alzheimer's disease: linking biomarkers to clinical practice. | Front Dement | 2026 | https://conductscience.org/library/papers/41756762 | PubMed |
| 41683895 | Reduced Plasma Aβ Peptides but Stable NfL and GFAP in Major Depressive Disorder. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683895 | PubMed |
| 41252266 | Cross-sectional associations between lifecourse dementia risk factors, plasma neurodegenerative biomarkers, and cognition in older adults in India. | J Alzheimers Dis | 2026 | https://conductscience.org/library/papers/41252266 | PubMed |
| 41001466 | Cross-sectional associations between lifecourse dementia risk factors, plasma neurodegenerative biomarkers, and cognition in older adults in India. | medRxiv | 2025 | https://conductscience.org/library/papers/41001466 | PubMed |
| 40136456 | Older Amyloid Beta as a Candidate Blood Biomarker of Early Cognitive Decline in the Elderly-A Preliminary Study. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40136456 | PubMed |
| 40091634 | Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls. | Exp Neurobiol | 2025 | https://conductscience.org/library/papers/40091634 | PubMed |
| 40046335 | Plasma biomarkers for diagnosis and differentiation and their cognitive correlations in patients with Alzheimer's disease. | Brain Commun | 2025 | https://conductscience.org/library/papers/40046335 | PubMed |
| 40017276 | Association of Rapidly Elevated Plasma Tau Protein With Cognitive Decline in Patients With Amnestic Mild Cognitive Impairment and Alzheimer's Disease. | Psychiatry Investig | 2025 | https://conductscience.org/library/papers/40017276 | PubMed |
| 39881680 | MicroRNAs signatures as potential molecular markers in mild cognitive impairment: a meta-analysis. | Front Aging Neurosci | 2024 | https://conductscience.org/library/papers/39881680 | PubMed |
| 39474617 | Simple Plasma Test Based on a MoSe2 SERS Platform for the Specific Diagnosis of Alzheimer's Disease. | Chem Biomed Imaging | 2023 | https://conductscience.org/library/papers/39474617 | PubMed |
| 39309539 | Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives. | Adv Funct Mater | 2023 | https://conductscience.org/library/papers/39309539 | PubMed |
| 39185459 | Alzheimer's disease: a review on the current trends of the effective diagnosis and therapeutics. | Front Aging Neurosci | 2024 | https://conductscience.org/library/papers/39185459 | PubMed |
| 39125699 | Clinical Application of Blood Biomarkers in Neurodegenerative Diseases-Present and Future Perspectives. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125699 | PubMed |
| 39100640 | Advances in Blood Biomarkers for Alzheimer's Disease: Ultra-Sensitive Detection Technologies and Impact on Clinical Diagnosis. | Degener Neurol Neuromuscul Dis | 2024 | https://conductscience.org/library/papers/39100640 | PubMed |
| 39078432 | A mediation approach in resting-state connectivity between the medial prefrontal cortex and anterior cingulate in mild cognitive impairment. | Aging Clin Exp Res | 2024 | https://conductscience.org/library/papers/39078432 | PubMed |
| 37939982 | Menopausal vasomotor symptoms and plasma Alzheimer disease biomarkers. | Am J Obstet Gynecol | 2024 | https://conductscience.org/library/papers/37939982 | PubMed |
| 37762457 | Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762457 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18486992
GET https://conductscience.org/api/papers/v1/18486992/cited_by?page=2